| 1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice Y Li, C Wang, D Li, P Deng, X Shao, J Hu, C Liu, H Jie, Y Lin, Z Li, X Qian, ... Oncology Reports 38 (5), 3044-3054, 2017 | 13 | 2017 |
| Abstract PO-020: Inferring copy number substructure from single-cell transcriptomics in human tumors with CopyKat R Gao, S Bai, H Ying, Y Lin, T Seth, M Hu, E Sei, A Davis, F Wang, ... Cancer Research 80 (21_Supplement), PO-020-PO-020, 2020 | | 2020 |
| Adjuvant chemoradiotherapy vs chemotherapy for resectable biliary tract cancer: a propensity score matching analysis based on the SEER database Y Zhu, X Liu, Y Lin, L Tang, X Yi, H Xu, Y Yuan, Y Chen European Journal of Medical Research 28 (1), 310, 2023 | 1 | 2023 |
| Advancing cancer research and medicine with single-cell genomics B Lim, Y Lin, N Navin Cancer cell 37 (4), 456-470, 2020 | 218 | 2020 |
| Case report: Complete pathological admission in N3 unresectable locally advanced lung adenocarcinoma with a novel INTS10-ALK and EML4-ALK fusion after neoadjuvant crizotinib X Zhai, T Wang, Y Lin, J Zhang, Y Wang, W Wang, Q Zhou, D Zhu Frontiers in Oncology 13, 1104910, 2023 | | 2023 |
| Circadian regulator CLOCK promotes tumor angiogenesis in glioblastoma L Pang, M Dunterman, W Xuan, A Gonzalez, Y Lin, WH Hsu, F Khan, ... Cell reports 42 (2), 2023 | 24 | 2023 |
| Cocaine modifies brain lipidome in mice Y Lin, H Gu, L Jiang, W Xu, C Liu, Y Li, X Qian, D Li, Z Li, J Hu, H Zhang, ... Molecular and Cellular Neuroscience 85, 29-44, 2017 | 24 | 2017 |
| Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract O Alhalabi, N Wilson, L Xiao, Y Lin, J Khandelwal, MJ Moussa, P Msaouel, ... European Urology Oncology 6 (6), 611-620, 2023 | 1 | 2023 |
| Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation C Liu, L Wang, X Liu, Y Tan, L Tao, Y Xiao, P Deng, H Wang, Q Deng, ... Theranostics 11 (6), 2966, 2021 | 40 | 2021 |
| Decoding the archetypes and eco-hubs of triple-negative breast cancer in responses to chemotherapy Y Yan, Y Lin, T Kumar, S Bai, J Li, T Tran, M Hu, E Ravenberg, M Rauch, ... Cancer Research 84 (6_Supplement), 6933-6933, 2024 | | 2024 |
| Decoding the natural biology of triple-negative breast cancer and response to chemotherapy by single-cell transcriptomics T Kumar, Y Lin, Y Yan, S Bai, J Li, T Tran, M Hu, E Ravenberg, M Rauch, ... Cancer Research 83 (7_Supplement), 2147-2147, 2023 | | 2023 |
| Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes R Gao, S Bai, YC Henderson, Y Lin, A Schalck, Y Yan, T Kumar, M Hu, ... Nature biotechnology 39 (5), 599-608, 2021 | 378 | 2021 |
| Ferroptosis in Cancer Immunity and Immunotherapy: Multifaceted Interplay and Clinical Implications X Zhai, Y Lin, L Zhu, Y Wang, J Zhang, J Liu, L Li, X Lu Cytokine & Growth Factor Reviews, 2023 | 4 | 2023 |
| Gas6/AXL pathway: immunological landscape and therapeutic potential X Zhai, D Pu, R Wang, J Zhang, Y Lin, Y Wang, N Zhai, X Peng, Q Zhou, ... Frontiers in Oncology 13, 1121130, 2023 | 3 | 2023 |
| High throughput single cell simultaneous DNA and RNA sequencing identified cell-of-origin of breast cancer K Wang, R Ye, S Bai, Z Xiao, L Yano, J Li, Y Lin, E Sei, S Lin, A Thompson, ... Cancer Research 84 (6_Supplement), 6937-6937, 2024 | | 2024 |
| Identification of immune subtypes of lung squamous cell carcinoma by integrative genome-scale analysis L Yin, W Zhang, D Pu, X Zhai, Y Lin, Q Wu, T Chang, J Hu, Y Li, Q Zhou Frontiers in oncology 11, 778549, 2022 | 2 | 2022 |
| Integrative clinical and genomic characterization of MTAP-deficient metastatic urothelial cancer O Alhalabi, Y Zhu, A Hamza, W Qiao, Y Lin, RM Wang, AY Shah, ... European Urology Oncology 6 (2), 228-232, 2023 | 17 | 2023 |
| Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression F Khan, Y Lin, H Ali, L Pang, M Dunterman, WH Hsu, K Frenis, ... Nature communications 15 (1), 1987, 2024 | | 2024 |
| LC‑MS/MS metabolome analysis detects the changes in the lipid metabolic profiles of dMMR and pMMR cells W Peng, S Tan, Y Xu, L Wang, D Qiu, C Cheng, Y Lin, C Liu, Z Li, Y Li, ... Oncology reports 40 (2), 1026-1034, 2018 | 19 | 2018 |
| Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment Y Li, X Qian, Y Lin, L Tao, Z Zuo, H Zhang, S Yang, X Cen, Y Zhao Oncology Reports 46 (5), 1-15, 2021 | 5 | 2021 |
Nicholas NavinMD Anderson Cancer Center在 mdanderson.org 的电子邮件经过验证
Nicholas NavinMD Anderson Cancer Center在 mdanderson.org 的电子邮件经过验证